Analystreport

Organogenesis (NASDAQ:ORGO) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $7.00 price target on the stock.

Organogenesis Holdings Inc. - Class A  (ORGO) 
Last organogenesis holdings inc. - class a earnings: 3/9 04:05 pm Check Earnings Report